Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 6.61
- Piotroski Score 4.00
- Grade Outperform
- Symbol (RGEN)
- Company Repligen Corporation
- Price $138.82
- Changes Percentage (-0.06%)
- Change -$0.08
- Day Low $136.54
- Day High $139.61
- Year High $211.13
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and SpectraFlo dynamic dialysis systems; and ProConnex single-use hollow fiber. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/19/2025
- Fiscal Year End N/A
- Average Stock Price Target $200.00
- High Stock Price Target $220.00
- Low Stock Price Target $155.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.27
- Trailing P/E Ratio 539.93
- Forward P/E Ratio 539.93
- P/E Growth 539.93
- Net Income $41.58 M
Income Statement
Quarterly
Annual
Latest News of RGEN
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Pittsburgh Bureau of Fire Battalion Chief John Walsh dies of medical emergency at East Hills fire scene
Pittsburgh Bureau of Fire Battalion Chief John Walsh passed away after a medical emergency while commanding a house fire response. With 37 years of dedicated service, he was honored by various fire de...
By CBS News | 8 hours ago -
Urgent need for Baltimore's Key Bridge construction funding explained to Congress
Maryland delegation urges Congress to pass President Biden's $100 billion disaster supplement quickly. Funding for Francis Scott Key Bridge reconstruction and Small Business Administration loans is cr...
By CBS News | 17 hours ago -
Billionaire's Son Wins Emergency Control Of His Aging Father's Nursing Home Empire
Aubrey Preston, son of Tennessee nursing home tycoon Forrest Preston, has gained temporary control over his father's $3 billion nursing home empire amid allegations of incapacity and financial miscond...
By Forbes | 19 hours ago
